Results 111 to 120 of about 119,314 (303)
Proteolytic and peptidase activities of the jejunum and ileum of the rat during postnatal development [PDF]
R. Noack+5 more
openalex +1 more source
Clinical guideline for postoperative nutrition support in neonates with enterostomy (2024)
ABSTRACT This is an evidence‐based guideline for postoperative nutritional management of neonates with enterostomy. There were 10 clinical questions in enteral nutrition management, parenteral nutrition management, and post‐discharge follow‐up (including the closure of fistula).
Beijing Children's Hospital+2 more
wiley +1 more source
Action of 5-hydroxytryptamine on the human stomach, duodenum, and jejunum in vitro. [PDF]
D. J. FISHLOCK, A G Parks, J V Dewell
openalex +1 more source
Abstract Central nervous system (CNS) involvement in peripheral T‐cell lymphoma (PTCL) is rare and is associated with poor prognosis. This report presents two pathologically confirmed PTCL cases. Although cerebrospinal fluid (CSF) flow cytometry did not detect tumor cells, CSF analysis revealed significantly elevated interleukin (IL)‐10 levels and an ...
Xin Wang+5 more
wiley +1 more source
SEVERE INTESTINAL HEMORRHAGE DUE TO LEIOMYOMA OF THE JEJUNUM
Prince Philip
openalex +2 more sources
Responses of the Smooth Muscle Membrane of Guinea Pig Jejunum Elicited by Field Stimulation [PDF]
T. Hidaka, H Kuriyama
openalex +1 more source
Harnessing synthetic key receptor modulators, this study presents a breakthrough in Wnt/β‐catenin regulation. The FZD agonist RRP‐pbFn bypasses LRP5/6 to drive organoid expansion and tissue regeneration, while the LRP antagonist RRP‐Dkk1c eradicates tumors. These tools enable precise pathway control, advancing regenerative and cancer therapies.
Quanhui Dai+9 more
wiley +1 more source
Chronic intestinal pseudo-obstruction in a Bernese Mountain Dog [PDF]
Chronic Intestinal Pseudo-Obstruction (CIPO) is a rare syndrome characterized by chronic intestinal dilation and dysmotility in the absence of mechanical obstruction.
Chiers, Koen+5 more
core
Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers
Oral delivery is a preferred administration route for many clinical applications, valued for its strong patient compliance. In this review, how nanoparticles are engineered and deployed to overcome the gastrointestinal barriers that impede clinical translation of oral delivery formulations is examined.
Luke J. Kubiatowicz+5 more
wiley +1 more source